北美乳房重建市場規模、佔有率、趨勢分析報告：按產品、形狀、最終用途、地區和細分市場預測，2023-2030 年

北美乳房重建市場的成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，北美乳房重建市場規模預計將達到 3.662 億美元，2023 年至 2030 年年複合成長率為 6.8%。

這是由於該地區乳癌患者數量不斷增加。例如，根據加拿大癌症協會 2019 年的數據，八分之一的女性將被診斷出罹患乳癌。此外，根據類似資訊來源，乳癌是加拿大第二大常見癌症。因此，加拿大乳癌患者數量的增加預計將推動北美乳房重建市場的發展。

此外，該地區的乳房重建手術數量正在增加。例如，根據整形外科檔案館的數據，乳房重建術後乳房重建手術從2015年的19.4%增加到2018年的53.4%。同樣，根據加拿大癌症協會的數據，加拿大五分之一的女性在乳房切除術後接受了乳房重建。因此，乳房重建手術數量的增加預計將推動北美乳房重建市場。

此外，各種宣傳活動的開展也提高了婦女的意識。例如，乳房重建意識運動教育、參與並賦予婦女權力，讓她們在乳癌診斷後就乳房重建做出正確的決定。

由於COVID-19的影響，北美乳房重建市場有所下滑。然而，大流行後，市場預計將出現顯著的成長。預計在 COVID-19 期間推遲的擇期手術（例如乳房植入手術）也將在 COVID-19 後期進行。此外，為了佔領市場，許多公司正在採取各種策略，例如地理擴張、產品發布和聯盟。

例如，2021 年 4 月，Sientra, Inc. 和 Butterfly Network 宣佈建立策略夥伴關係，以改善乳房植入患者的診斷監測。預計這將有助於增強公司的安全狀況，並得到其 Platinum20 保固計畫的支持。因此，此類案例預計將推動 COVID-19 後北美乳房重建市場的發展。

北美乳房重建市場報告亮點

• 依按產品分類，植體部門佔最大市場佔有率，2022年將達63.5%。然而，組織擴張器領域預計在預測期內以 6.9% 的年複合成長率年成長率發展最快。這是由於組織擴張器領域產品的進步。
• 從形狀來看，圓形扇形佔比最大，2022年將達55.3%。然而，在預測期內，解剖形狀預計將呈現最快的成長率，年複合成長率為 6.9%。
• 根據最終用途，醫院細分市場預計將在 2022 年以 55.3% 的佔有率主導市場。然而，美容診所領域預計在預測期內將出現最高成長率，年複合成長率為 7.0%。這是由於北美地區美髮師數量不斷增加。
• 從區域來看，美國佔市場主導地位，2022 年銷售佔有率最大，達 74.4%。這是由於該國乳癌和乳房重建手術數量的增加。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 北美乳房重建市場變數、趨勢與範圍

• 市場體系預測
  • 母市場預測
  • 相關/附隨市場預測
• 普及和成長預測圖
• 市場動態
  • 市場促進因素分析
  • 市場抑制因素分析
• 北美乳房重建市場分析工具
  • 產業分析-波特五力分析
  • PESTEL分析

第4章 北美乳房重建市場：產品評估與趨勢分析

• 北美乳房重建市場：重點
• 北美乳房重建市場：2022年及2030年產品趨勢及市場佔有率分析
• 注入
• 組織擴張器
• 去細胞真皮基質

第5章 北美乳房重建市場：形狀估計與趨勢分析

• 北美乳房重建市場：重點
• 北美乳房重建市場：2022 年和 2030 年形狀變化和市場佔有率分析
• 圓形
• 解剖形狀

第6章 北美乳房重建市場：最終用途估計與趨勢分析

• 北美乳房重建市場：重點
• 北美乳房重建市場：2022 年和 2030 年最終用途趨勢和市場佔有率分析
• 醫院
• 美容診所
• 門診手術中心

第7章 北美乳房重建市場：區域估計與趨勢分析

• 區域預測
• 按地區分類的北美乳房重建市場：要點
• 北美洲
  • 2018-2030 年市場估計與預測
  • 美國
  • 加拿大

第8章 競爭形勢

• 主要市場參與企業的最新趨勢和影響分析
• 市場參與企業分類
  • Mentor Worldwide LLC
  • AbbVie Inc.
  • Integra LifeSciences
  • Sientra, Inc.
  • Stryker
  • Establishment Labs
  • RTI Surgical
  • MTF Biologics
  • Surgical Innovation Associates
  • TELA Bio, Inc.

North America Breast Reconstruction Market Growth & Trends:

The North America breast reconstruction market size is expected to reach USD 366.2 million by 2030, registering a CAGR of 6.8% from 2023 to 2030, according to a new report by Grand View Research, Inc..This can be credited to the increase in number of breast cancer patients within this region. For instance, as per the Canadian Cancer Society 2019, one in eight females is expected to be diagnosed with breast cancer. Moreover, as per a similar source, breast cancer is the second most occurring cancer in Canada. Thus, the increasing number of breast cancer patients in Canada is predicted to boost the North America Breast Reconstruction market.

Moreover, the number of breast reconstruction surgery is also increasing in this region. For instance, as per the Archives of Plastic Surgery, post-mastectomy breast reconstruction surgery has increased from 19.4% in 2015 to 53.4% in 2018. Similarly, as per the Canadian Cancer Society, one in every five women in Canada goes under breast reconstruction post-mastectomy. Thus, a rise in the number of breast reconstruction surgery is anticipated to drive the North America breast reconstruction market.

Furthermore, the initiation of various awareness campaigns is leading to rising awareness among women. For instance, the Breast Reconstruction Awareness Campaign educates, engages & empowers females to take the right decision regarding breast reconstruction, post breast cancer diagnosis.

The North America breast reconstruction market witnessed a dip due to COVID-19. However, post-pandemic, the market is projected to have a significant growth rate. Elective surgeries such as breast augmentation, which were postponed during COVID-19, are expected to be held in the post-COVID-19 period. Moreover, to capture the market, many companies are entering into various strategies such as geographic expansion, product launches, and partnerships.

For instance, in April 2021, Sientra, Inc. and the Butterfly Network announced a strategic partnership to improve diagnostic surveillance of breast implant patients. This was expected to help the company to strengthen its safety profile, which was backed by the Platinum20 warranty program. Therefore, such instances are expected to drive the North America breast reconstruction market in the post-COVID-19 period.

North America Breast Reconstruction Market Report Highlights:

• In terms of product, the implants segment held the largest market share of 63.5% in 2022 in the market. However, the tissue expander segment is expected to develop with the fastest growth rate of 6.9% CAGR, during the forecast period. This can be credited to the advancement in the products within the tissue expander segment
• Based on shape, the round shape segment held the largest share of 55.3% in 2022 in the market. However, the anatomical shape is anticipated to witness the fastest growth rate of CAGR of 6.9% during the forecast period
• Based on end-use, the hospital segment was expected to dominate the market with a 55.3% share during 2022. However, the cosmetology clinics segment is projected to witness the highest growth rate of 7.0% CAGR during the forecast period. This can be credited to the rising number of cosmetologists in the North America region.
• Based on the region, the U.S. dominated the market with the largest revenue share of 74.4% in 2022. This can be credited to the increase in number of breast cancer & breast reconstruction procedures within this nation

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Shape
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Shape outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. North America Breast Reconstruction Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. North America Breast Reconstruction Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. North America Breast Reconstruction Market: Product Estimates & Trend Analysis

• 4.1. North America Breast Reconstruction Market: Key Takeaways
• 4.2. North America Breast Reconstruction Market: Product Movement & Market Share Analysis, 2022 & 2030
• 4.3. Implants
  • 4.3.1. Implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.2. Silicone breast implants
    • 4.3.2.1. Silicone breast implants estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.3. Saline breast implants
    • 4.3.3.1. Saline breast implants estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Tissue Expander
  • 4.4.1. Tissue expander market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Saline expander
    • 4.4.2.1. Saline expander estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Air tissue expander
    • 4.4.3.1. Air tissue expander estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Acellular Dermal Matrix
  • 4.5.1. Acellular dermal matrix market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. North America Breast Reconstruction Market: Shape Estimates & Trend Analysis

• 5.1. North America Breast Reconstruction Market: Key Takeaways
• 5.2. North America Breast Reconstruction Market: Shape Movement & Market Share Analysis, 2022 & 2030
• 5.3. Round Shape
  • 5.3.1. Round shape market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Anatomical Shape
  • 5.4.1. Anatomical shape market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. North America Breast Reconstruction Market: End Use Estimates & Trend Analysis

• 6.1. North America Breast Reconstruction Market: Key Takeaways
• 6.2. North America Breast Reconstruction Market: End-use Movement & Market Share Analysis, 2022 & 2030
• 6.3. Hospitals
  • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Cosmetology Clinics
  • 6.4.1. Cosmetology clinics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. North America Breast Reconstruction Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. North America Breast Reconstruction Market by Region: Key Takeaways
• 7.3. North America
  • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. Mentor Worldwide LLC
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. AbbVie Inc.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Integra LifeSciences
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Sientra, Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Stryker
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Establishment Labs
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. RTI Surgical
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. MTF Biologics
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Surgical Innovation Associates
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. TELA Bio, Inc.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America North America breast reconstruction market, by product, 2018 - 2030 (USD Million)
• Table 3 North America North America breast reconstruction market, by shape, 2018 - 2030 (USD Million)
• Table 4 North America North America breast reconstruction market, by end use, 2018 - 2030 (USD Million)
• Table 5 North America North America breast reconstruction market, by region, 2018 - 2030 (USD Million)
• Table 6 U.S. breast reconstruction market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. breast reconstruction market, by shape, 2018 - 2030 (USD Million)
• Table 8 U.S. breast reconstruction market, by end use, 2018 - 2030 (USD Million)
• Table 9 Canada breast reconstruction market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada breast reconstruction market, by shape, 2018 - 2030 (USD Million)
• Table 11 Canada breast reconstruction market, by end use, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 QFD modeling for market share assessment

Fig. 6 Market formulation & validation

Fig. 7 North America breast reconstruction: Market outlook

Fig. 8 North America breast reconstruction: Competitive insights

Fig. 9 Parent market outlook

Fig. 10 Related/ancillary market outlook

Fig. 11 Penetration and growth prospect mapping

Fig. 12 Industry value chain analysis

Fig. 13 North America breast reconstruction market driver impact

Fig. 14 North America breast reconstruction market restraint impact

Fig. 15 North America breast reconstruction market strategic initiatives analysis

Fig. 16 North America breast reconstruction market: Product movement analysis

Fig. 17 North America breast reconstruction market: Product outlook and key takeaways

Fig. 18 Implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 19 Silicone breast implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 20 Saline breast implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 21 Tissue expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 22 Saline expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 23 Air tissue expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 24 Acellular dermal matrix market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 25 North America breast reconstruction market: Shape movement analysis

Fig. 26 North America breast reconstruction market: Shape mode outlook and key takeaways

Fig. 27 Round shape market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 28 Anatomical shape market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 29 North America breast reconstruction market: End use movement analysis

Fig. 30 North America breast reconstruction market: End use outlook and key takeaways

Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 32 Cosmetology clinics market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 33 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 34 North America breast reconstruction market: Regional movement analysis

Fig. 35 North America breast reconstruction market: Regional outlook and key takeaways

Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)